1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804
Turnaround Potential
In 3 Starfolio Baskets
Download real time
1220.70 9.20 (0.76%)
Near 52W High of ₹1278.60
2.6M
NSE+BSE Volume

NSE 26 Feb, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Aurobindo Pharma's arm gets US FDA nod to market Everolimus tablets, with a market size of $78 mn See details